Significant Ownership of EcoR1 Capital, LLC

Notable people
Oleg Nodelman
Signature - Title
/s/ Oleg Nodelman - Manager
Location
San Francisco, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by EcoR1 Capital, LLC.

Notify me when EcoR1 Capital, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of EcoR1 Capital, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ZYME Zymeworks Inc. Common Stock 31% $420,817,508 22,970,388 0% EcoR1 Capital, LLC 16 Nov 2025
ITOS iTeos Therapeutics, Inc. Common Stock 28% $78,563,988 +$36,448,488 10,688,978 +87% EcoR1 Capital, LLC 15 May 2025
GLPG Galapagos NV Ordinary Shares, no par value 13% $220,651,697 +$23,074,622 8,714,522 +12% EcoR1 Capital, LLC 24 Jul 2025
NGNE Neurogene Inc. Common Stock 9.9% $25,005,492 1,442,902 EcoR1 Capital, LLC 30 Sep 2025
TNGX Tango Therapeutics, Inc. Common Stock 9.9% $13,501,035 10,630,736 EcoR1 Capital, LLC 31 Dec 2024
ATRA Atara Biotherapeutics, Inc. Common Stock 9.9% $8,626,029 715,853 EcoR1 Capital, LLC 30 Sep 2025
IBIO iBio, Inc. Common Stock 9.9% $2,673,600 2,228,000 EcoR1 Capital, LLC 10 Dec 2025
MREO Mereo BioPharma Group plc Ordinary Shares 9.4% $31,044,150 74,500,000 EcoR1 Capital, LLC 02 Jan 2026
Aktis Oncology, Inc. Common Stock 9.1% 4,862,335 Oleg Nodelman 12 Jan 2026
ALVR Allovir, Inc. Common Stock 8.1% $3,886,623 408,688 EcoR1 Capital, LLC 31 Dec 2024
ETON Eton Pharmaceuticals, Inc. Common Stock 7.7% $25,059,688 1,981,003 EcoR1 Capital, LLC 31 Dec 2024
QURE uniQure N.V. Ordinary Shares, par value(euro)0.05 per share 7.5% $33,269,917 3,632,087 EcoR1 Capital, LLC 10 Dec 2024
ORIC ORIC Pharmaceuticals, Inc. Common Stock 6.9% $35,726,296 6,728,116 EcoR1 Capital, LLC 29 Jul 2025
VYGR Voyager Therapeutics, Inc. Common Stock 6.8% $18,696,980 4,003,636 EcoR1 Capital, LLC 30 Sep 2025
KURA Kura Oncology, Inc. Common Stock 4.8% $25,284,000 4,200,000 EcoR1 Capital, LLC 30 Jun 2025
IMNM Immunome Inc. Common Stock 4.7% $28,963,846 4,079,415 EcoR1 Capital, LLC 31 Mar 2025
ADAP Adaptimmune Therapeutics PLC Ordinary Shares 4.2% $3,960,000 66,000,000 EcoR1 Capital, LLC 15 Aug 2025
AVIR Atea Pharmaceuticals, Inc. Common Stock 4% $9,991,542 3,341,653 EcoR1 Capital, LLC 31 Dec 2024
HOOK HOOKIPA Pharma Inc. Common Stock 4% $291,646 388,861 EcoR1 Capital, LLC 31 Dec 2024
ALGS Aligos Therapeutics, Inc. Common Stock 3.9% $859,387 210,634 EcoR1 Capital, LLC 31 Mar 2025
APLS Apellis Pharmaceuticals, Inc. Common Stock 2.7% $78,009,140 3,447,156 EcoR1 Capital, LLC 30 Sep 2025
WHWK Aadi Bioscience, Inc. Common Stock 1.4% $569,667 345,253 EcoR1 Capital, LLC 31 Dec 2024
TCRX TScan Therapeutics, Inc. Voting Common Stock 1.3% $841,798 662,833 EcoR1 Capital, LLC 31 Mar 2025
KLRS Kalaris Therapeutics, Inc. Common Stock 1.1% $1,619,796 201,718 EcoR1 Capital, LLC 31 Mar 2025
TECX Tectonic Therapeutic, Inc. Common Stock 0% $0 -$14,672,048 0 -100% EcoR1 Capital, LLC 30 Sep 2025
ARVN ARVINAS, INC. Common Stock 0% $0 0 EcoR1 Capital, LLC 31 Mar 2025
PRTA PROTHENA CORP PUBLIC LTD CO Ordinary Shares 0% $0 -$40,261,884 0 -100% EcoR1 Capital, LLC 27 May 2025
THRD Third Harmonic Bio, Inc. Common Stock 0% $0 0 EcoR1 Capital, LLC 31 Mar 2025
HLVX HilleVax, Inc. Common Stock 0% $0 -$6,044,280 0 -100% EcoR1 Capital, LLC 30 Sep 2025
MRSN Mersana Therapeutics, Inc. Common Stock 0% $0 -$3,473,534 0 -100% EcoR1 Capital, LLC 31 Mar 2025

Schedules 13D/G Reported by EcoR1 Capital, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.